Ovid Therapeutics (OVID)
(Delayed Data from NSDQ)
$1.15 USD
-0.02 (-1.71%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.16 +0.01 (0.87%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/01/2024
Time: -- |
9/2024 | $-0.19 | -14.78% |
Earnings Summary
For their last quarter, Ovid Therapeutics (OVID) reported earnings of $0.12 per share, beating the Zacks Consensus Estimate of $-0.22 per share. This reflects a positive earnings surprise of 154.55%. Look out for OVID's next earnings release expected on November 01, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year decrease of 18.75%.
Earnings History
Price & Consensus
Zacks News for OVID
Ovid Therapeutics (OVID) Q2 Earnings and Revenues Surpass Estimates
OVID: What are Zacks experts saying now?
Zacks Private Portfolio Services